A crucial factor in defining the switch in the TGF-β1 signaling pathway from tumor suppression to fibrogenesis, which accelerates liver fibrosis and raises the risk for HCC, is also the persistence of chronic inflammation, as seen in chronic viral hepatitis. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.